Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1236

1.

New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.

Tazarki H, Zeinyeh W, Esvan YJ, Knapp S, Chatterjee D, Schröder M, Joerger AC, Khiari J, Josselin B, Baratte B, Bach S, Ruchaud S, Anizon F, Giraud F, Moreau P.

Eur J Med Chem. 2019 Jan 26;166:304-317. doi: 10.1016/j.ejmech.2019.01.052. [Epub ahead of print]

PMID:
30731399
2.

Hidden fungal diversity from the Neotropics: Geastrum hirsutum, G. schweinitzii (Basidiomycota, Geastrales) and their allies.

Accioly T, Sousa JO, Moreau PA, Lécuru C, Silva BDB, Roy M, Gardes M, Baseia IG, Martín MP.

PLoS One. 2019 Feb 6;14(2):e0211388. doi: 10.1371/journal.pone.0211388. eCollection 2019.

3.

[Update of the recommendations of good clinical practice for the use of PET in oncology].

Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Lucian A, Cachin F.

Bull Cancer. 2019 Jan 22. pii: S0007-4551(19)30018-9. doi: 10.1016/j.bulcan.2019.01.002. [Epub ahead of print] French.

PMID:
30683308
4.

A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent towards acute myeloid leukemia.

Bjørnstad R, Aesoy R, Bruserud Ø, Brenner AK, Giraud F, Dowling TH, Gausdal G, Moreau P, Døskeland SO, Anizon F, Herfindal L.

Mol Cancer Ther. 2019 Jan 24. pii: molcanther.1234.2017. doi: 10.1158/1535-7163.MCT-17-1234. [Epub ahead of print]

PMID:
30679386
5.

FLT3 ligand plasma levels in acute myeloid leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuillem S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Haematologica. 2019 Jan 10. pii: haematol.2018.209460. doi: 10.3324/haematol.2018.209460. [Epub ahead of print]

6.

Diversity of Chroogomphus (Gomphidiaceae, Boletales) in Europe, and typification of C. rutilus.

Scambler R, Niskanen T, Assyov B, Ainsworth AM, Bellanger JM, Loizides M, Moreau PA, Kirk PM, Liimatainen K.

IMA Fungus. 2018 Jul;9:271-290. doi: 10.5598/imafungus.2018.09.02.04. Epub 2018 Sep 5.

7.

Posterior dislocation of the long head biceps tendon: a case report, specific radiographic finding, and review of the literature.

Moreau P, Bresler M, Goldberg B, Mar WA.

Skeletal Radiol. 2019 Jan 5. doi: 10.1007/s00256-018-3137-8. [Epub ahead of print]

PMID:
30612160
8.

Acto-myosin force organization modulates centriole separation and PLK4 recruitment to ensure centriole fidelity.

Vitiello E, Moreau P, Nunes V, Mettouchi A, Maiato H, Ferreira JG, Wang I, Balland M.

Nat Commun. 2019 Jan 3;10(1):52. doi: 10.1038/s41467-018-07965-6.

9.

Percutaneous fixation of thoracolumbar vertebral fractures.

Sebaaly A, Rizkallah M, Riouallon G, Wang Z, Moreau PE, Bachour F, Maalouf G.

EFORT Open Rev. 2018 Nov 19;3(11):604-613. doi: 10.1302/2058-5241.3.170026. eCollection 2018 Nov.

10.

Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements.

Dejoie T, Corre J, Caillon H, Moreau P, Attal M, Loiseau HA.

Leukemia. 2019 Feb;33(2):313-318. doi: 10.1038/s41375-018-0339-y. Epub 2018 Dec 20. Review.

11.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10.

PMID:
30545780
12.

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.

Tessoulin B, Moreau-Aubry A, Descamps G, Gomez-Bougie P, Maïga S, Gaignard A, Chiron D, Ménoret E, Le Gouill S, Moreau P, Amiot M, Pellat-Deceunynck C.

J Hematol Oncol. 2018 Dec 13;11(1):137. doi: 10.1186/s13045-018-0679-0.

13.

p53 regulates CD46 expression and measles virus infection in myeloma cells.

Lok A, Descamps G, Tessoulin B, Chiron D, Eveillard M, Godon C, Le Bris Y, Vabret A, Bellanger C, Maillet L, Barillé-Nion S, Gregoire M, Fonteneau JF, Le Gouill S, Moreau P, Tangy F, Amiot M, Moreau-Aubry A, Pellat-Deceunynck C.

Blood Adv. 2018 Dec 11;2(23):3492-3505. doi: 10.1182/bloodadvances.2018025106.

14.

Fungal Planet description sheets: 716-784.

Crous PW, Wingfield MJ, Burgess TI, Hardy GESJ, Gené J, Guarro J, Baseia IG, García D, Gusmão LFP, Souza-Motta CM, Thangavel R, Adamčík S, Barili A, Barnes CW, Bezerra JDP, Bordallo JJ, Cano-Lira JF, de Oliveira RJV, Ercole E, Hubka V, Iturrieta-González I, Kubátová A, Martín MP, Moreau PA, Morte A, Ordoñez ME, Rodríguez A, Stchigel AM, Vizzini A, Abdollahzadeh J, Abreu VP, Adamčíková K, Albuquerque GMR, Alexandrova AV, Álvarez Duarte E, Armstrong-Cho C, Banniza S, Barbosa RN, Bellanger JM, Bezerra JL, Cabral TS, Caboň M, Caicedo E, Cantillo T, Carnegie AJ, Carmo LT, Castañeda-Ruiz RF, Clement CR, Čmoková A, Conceição LB, Cruz RHSF, Damm U, da Silva BDB, da Silva GA, da Silva RMF, de A Santiago ALCM, de Oliveira LF, de Souza CAF, Déniel F, Dima B, Dong G, Edwards J, Félix CR, Fournier J, Gibertoni TB, Hosaka K, Iturriaga T, Jadan M, Jany JL, Jurjević Ž, Kolařík M, Kušan I, Landell MF, Leite Cordeiro TR, Lima DX, Loizides M, Luo S, Machado AR, Madrid H, Magalhães OMC, Marinho P, Matočec N, Mešić A, Miller AN, Morozova OV, Neves RP, Nonaka K, Nováková A, Oberlies NH, Oliveira-Filho JRC, Oliveira TGL, Papp V, Pereira OL, Perrone G, Peterson SW, Pham THG, Raja HA, Raudabaugh DB, Řehulka J, Rodríguez-Andrade E, Saba M, Schauflerová A, Shivas RG, Simonini G, Siqueira JPZ, Sousa JO, Stajsic V, Svetasheva T, Tan YP, Tkalčec Z, Ullah S, Valente P, Valenzuela-Lopez N, Abrinbana M, Viana Marques DA, Wong PTW, Xavier de Lima V, Groenewald JZ.

Persoonia. 2018 Dec;40:240-393. doi: 10.3767/persoonia.2018.40.10. Epub 2018 Jul 13.

15.

Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.

Bouard L, Bodet-Milin C, Bailly C, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Bonnet A, Béné MC, Gouill SL, Moreau P, Kraeber-Bodéré F, Chevallier P.

Biol Blood Marrow Transplant. 2018 Nov 24. pii: S1083-8791(18)30752-3. doi: 10.1016/j.bbmt.2018.11.019. [Epub ahead of print]

PMID:
30481598
16.

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.

Usmani SZ, Hoering A, Cavo M, Miguel JS, Goldschimdt H, Hajek R, Turesson I, Lahuerta JJ, Attal M, Barlogie B, Lee JH, Kumar S, Lenhoff S, Morgan G, Rajkumar SV, Durie BGM, Moreau P.

Blood Cancer J. 2018 Nov 23;8(12):123. doi: 10.1038/s41408-018-0155-7.

17.

Cellular tension encodes local Src-dependent differential β1 and β3 integrin mobility.

De Mets R, Wang I, Balland M, Oddou C, Moreau P, Fourcade B, Albiges-Rizo C, Delon A, Destaing O.

Mol Biol Cell. 2019 Jan 15;30(2):181-190. doi: 10.1091/mbc.E18-04-0253. Epub 2018 Nov 21.

PMID:
30462575
18.

Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells.

Moreau PR, Örd T, Downes NL, Niskanen H, Bouvy-Liivrand M, Aavik E, Ylä-Herttuala S, Kaikkonen MU.

Front Cardiovasc Med. 2018 Nov 5;5:159. doi: 10.3389/fcvm.2018.00159. eCollection 2018.

19.

HLA-G, -E and -F regulatory and coding region variability and haplotypes in the Beninese Toffin population sample.

Sonon P, Sadissou I, Tokplonou L, M'po KKG, Glitho SSC, Agniwo P, Ibikounlé M, Massaro JD, Massougbodji A, Moreau P, Sabbagh A, Mendes-Junior CT, Moutairou KA, Castelli EC, Courtin D, Donadi EA.

Mol Immunol. 2018 Dec;104:108-127. doi: 10.1016/j.molimm.2018.08.016.

PMID:
30448608
20.

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting.

Richardson PG, San Miguel JF, Moreau P, Hajek R, Dimopoulos MA, Laubach JP, Palumbo A, Luptakova K, Romanus D, Skacel T, Kumar SK, Anderson KC.

Blood Cancer J. 2018 Nov 9;8(11):109. doi: 10.1038/s41408-018-0141-0. Review.

21.

A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.

Boutault R, Peterlin P, Boubaya M, Sockel K, Chevallier P, Garnier A, Guillaume T, Le Bourgeois A, Debord C, Godon C, Le Bris Y, Theisen O, Kroschinsky F, Moreau P, Béné MC, Platzbecker U, Eveillard M.

Br J Haematol. 2018 Dec;183(5):736-746. doi: 10.1111/bjh.15626. Epub 2018 Nov 8.

PMID:
30406952
22.

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.

Dimopoulos MA, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, Leleu X, LeBlanc R, Suzuki K, Raab MS, Richardson PG, Popa McKiver M, Jou YM, Shelat SG, Robbins M, Rafferty B, San-Miguel J.

N Engl J Med. 2018 Nov 8;379(19):1811-1822. doi: 10.1056/NEJMoa1805762.

PMID:
30403938
23.

The new magnetic diagnostics in the WEST tokamak.

Moreau P, Le-Luyer A, Spuig P, Malard P, Saint-Laurent F, Artaud JF, Morales J, Faugeras B, Heumann H, Cantone B, Moreau M, Brun C, Nouailletas R, Nardon E, Santraine B, Berne A, Kumari P, Belsare S; WEST Team.

Rev Sci Instrum. 2018 Oct;89(10):10J109. doi: 10.1063/1.5036537.

PMID:
30399836
24.

Steady state magnetic sensors for ITER and beyond: Development and final design (invited).

Kocan M, Duran I, Entler S, Vayakis G, Agostinetti P, Brombin M, Carmona JM, Gambetta G, Jirman T, Marconato N, Moreau P, Peruzzo S, Spuig P, Walsh M.

Rev Sci Instrum. 2018 Oct;89(10):10J119. doi: 10.1063/1.5038871.

PMID:
30399664
25.

Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis.

Grillon A, Scherlinger M, Boyer PH, De Martino S, Perdriger A, Blasquez A, Wipff J, Korganow AS, Bonnard C, Cantagrel A, Eyer D, Guérin F, Monteiro I, Woehl JM, Moreau P, Pennaforte JL, Lechevallier J, Bastides F, Colombey A, Imbert I, Maugars Y, Gicquel P, Cuchet F, Brax M, Sibilia J, Zilliox L, Barthel C, Arnaud L, Jaulhac B.

Semin Arthritis Rheum. 2018 Sep 28. pii: S0049-0172(18)30424-4. doi: 10.1016/j.semarthrit.2018.09.007. [Epub ahead of print]

PMID:
30344080
26.

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies.

Chevallier P, Peterlin P, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Le Bris Y, Béné MC, Le Gouill S, Moreau P, Guillaume T.

Oncotarget. 2018 Sep 11;9(71):33528-33535. doi: 10.18632/oncotarget.26083. eCollection 2018 Sep 11.

27.

Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin.

Moreau P, Cournac A, Palumbo GA, Marbouty M, Mortaza S, Thierry A, Cairo S, Lavigne M, Koszul R, Neuveut C.

Nat Commun. 2018 Oct 15;9(1):4268. doi: 10.1038/s41467-018-06739-4.

28.

BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment.

Gomez-Bougie P, Maiga S, Tessoulin B, Bourcier J, Bonnet A, Rodriguez MS, Le Gouill S, Touzeau C, Moreau P, Pellat-Deceunynck C, Amiot M.

Blood. 2018 Dec 20;132(25):2656-2669. doi: 10.1182/blood-2018-03-836718. Epub 2018 Oct 11.

PMID:
30309889
29.

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.

Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S.

Blood Cancer J. 2018 Oct 4;8(10):95. doi: 10.1038/s41408-018-0124-1.

30.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Garderet L, Kuhnowski F, Berge B, Roussel M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A, Moreau P, Marit G, Stoppa AM, Royer B, Chaleteix C, Tiab M, Araujo C, Lenain P, Macro M, Voog E, Benboubker L, Allangba O, Jourdan E, Orsini-Piocelle F, Brechignac S, Eveillard JR, Belhadj K, Wetterwald M, Pegourie B, Jaccard A, Eisenmann JC, Glaisner S, Mohty M, Hulin C, Loiseau HA, Mathiot C, Attal M.

Blood. 2018 Dec 13;132(24):2555-2563. doi: 10.1182/blood-2018-07-863829. Epub 2018 Oct 3.

PMID:
30282798
31.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

PMID:
30249784
32.

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.

Dimopoulos MA, San-Miguel J, Belch A, White D, Benboubker L, Cook G, Leiba M, Morton J, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL, Sutherland HJ, Lalancette M, Magen H, Iida S, Kim JS, Prince HM, Cochrane T, Oriol A, Bahlis NJ, Chari A, O' Rourke L, Wu K, Schecter JM, Casneuf T, Chiu C, Soong D, Sasser AK, Khokhar NZ, Avet-Loiseau H, Usmani SZ.

Haematologica. 2018 Sep 20. pii: haematol.2018.194282. doi: 10.3324/haematol.2018.194282. [Epub ahead of print]

33.

Global Approaches in Myeloma: Critical Trials That May Change Practice.

Moreau P, Touzeau C.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):656-661. doi: 10.1200/EDBK_200841. Review.

PMID:
30231332
34.

Experimental Limits of Ghost Diffraction: Popper's Thought Experiment.

Moreau PA, Morris PA, Toninelli E, Gregory T, Aspden RS, Spalding G, Boyd RW, Padgett MJ.

Sci Rep. 2018 Sep 4;8(1):13183. doi: 10.1038/s41598-018-31429-y.

35.

Genomic patterns of progression in smoldering multiple myeloma.

Bolli N, Maura F, Minvielle S, Gloznik D, Szalat R, Fullam A, Martincorena I, Dawson KJ, Samur MK, Zamora J, Tarpey P, Davies H, Fulciniti M, Shammas MA, Tai YT, Magrangeas F, Moreau P, Corradini P, Anderson K, Alexandrov L, Wedge DC, Avet-Loiseau H, Campbell P, Munshi N.

Nat Commun. 2018 Aug 22;9(1):3363. doi: 10.1038/s41467-018-05058-y.

36.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

PMID:
30098165
37.

Targeting Bcl-2 for the treatment of multiple myeloma.

Touzeau C, Maciag P, Amiot M, Moreau P.

Leukemia. 2018 Sep;32(9):1899-1907. doi: 10.1038/s41375-018-0223-9. Epub 2018 Aug 3. Review.

PMID:
30076373
38.

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.

Bailly C, Carlier T, Jamet B, Eugene T, Touzeau C, Attal M, Hulin C, Facon T, Leleu X, Perrot A, Garderet L, Macro M, Caillot D, Moreau P, Kraeber-Bodéré F, Bodet-Milin C.

Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1.

PMID:
30068709
39.

Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.

Qian X, Dimopoulos MA, Amatangelo M, Bjorklund C, Towfic F, Flynt E, Weisel KC, Ocio EM, Yu X, Peluso T, Sternas L, Zaki M, Moreau P, Thakurta A.

Leuk Lymphoma. 2018 Aug 2:1-9. doi: 10.1080/10428194.2018.1485915. [Epub ahead of print]

PMID:
30068263
40.

Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.

Norwood J, Pastoret C, Luycx O, Le Coz MF, Moreau P, Trebouet A, Niault M, Launay V, Allangba O, Bareau B, Doncker V, Grulois I, Jacomy D, Le Dû K, Henry C, Le Pabic E, Boulland ML, Fest T, Lamy T, Escoffre-Barbe M.

Am J Hematol. 2018 Oct;93(10):E329-E331. doi: 10.1002/ajh.25217. Epub 2018 Sep 30. No abstract available.

PMID:
30019460
41.

Considerations and consequences of allowing DNA sequence data as types of fungal taxa.

Zamora JC, Svensson M, Kirschner R, Olariaga I, Ryman S, Parra LA, Geml J, Rosling A, Adamčík S, Ahti T, Aime MC, Ainsworth AM, Albert L, Albertó E, García AA, Ageev D, Agerer R, Aguirre-Hudson B, Ammirati J, Andersson H, Angelini C, Antonín V, Aoki T, Aptroot A, Argaud D, Sosa BIA, Aronsen A, Arup U, Asgari B, Assyov B, Atienza V, Bandini D, Baptista-Ferreira JL, Baral HO, Baroni T, Barreto RW, Beker H, Bell A, Bellanger JM, Bellù F, Bemmann M, Bendiksby M, Bendiksen E, Bendiksen K, Benedek L, Bérešová-Guttová A, Berger F, Berndt R, Bernicchia A, Biketova AY, Bizio E, Bjork C, Boekhout T, Boertmann D, Böhning T, Boittin F, Boluda CG, Boomsluiter MW, Borovička J, Brandrud TE, Braun U, Brodo I, Bulyonkova T, Burdsall HH Jr, Buyck B, Burgaz AR, Calatayud V, Callac P, Campo E, Candusso M, Capoen B, Carbó J, Carbone M, Castañeda-Ruiz RF, Castellano MA, Chen J, Clerc P, Consiglio G, Corriol G, Courtecuisse R, Crespo A, Cripps C, Crous PW, da Silva GA, da Silva M, Dam M, Dam N, Dämmrich F, Das K, Davies L, De Crop E, De Kesel A, De Lange R, De Madrignac Bonzi B, Dela Cruz TEE, Delgat L, Demoulin V, Desjardin DE, Diederich P, Dima B, Dios MM, Divakar PK, Douanla-Meli C, Douglas B, Drechsler-Santos ER, Dyer PS, Eberhardt U, Ertz D, Esteve-Raventós F, Salazar JAE, Evenson V, Eyssartier G, Farkas E, Favre A, Fedosova AG, Filippa M, Finy P, Flakus A, Fos S, Fournier J, Fraiture A, Franchi P, Molano AEF, Friebes G, Frisch A, Fryday A, Furci G, Márquez RG, Garbelotto M, García-Martín JM, Otálora MAG, Sánchez DG, Gardiennet A, Garnica S, Benavent IG, Gates G, da Cruz Lima Gerlach A, Ghobad-Nejhad M, Gibertoni TB, Grebenc T, Greilhuber I, Grishkan B, Groenewald JZ, Grube M, Gruhn G, Gueidan C, Gulden G, Gusmão LF, Hafellner J, Hairaud M, Halama M, Hallenberg N, Halling RE, Hansen K, Harder CB, Heilmann-Clausen J, Helleman S, Henriot A, Hernandez-Restrepo M, Herve R, Hobart C, Hoffmeister M, Høiland K, Holec J, Holien H, Hughes K, Hubka V, Huhtinen S, Ivančević B, Jagers M, Jaklitsch W, Jansen A, Jayawardena RS, Jeppesen TS, Jeppson M, Johnston P, Jørgensen PM, Kärnefelt I, Kalinina LB, Kantvilas G, Karadelev M, Kasuya T, Kautmanová I, Kerrigan RW, Kirchmair M, Kiyashko A, Knapp DG, Knudsen H, Knudsen K, Knutsson T, Kolařík M, Kõljalg U, Košuthová A, Koszka A, Kotiranta H, Kotkova V, Koukol O, Kout J, Kovács GM, Kříž M, Kruys Å, Kučera V, Kudzma L, Kuhar F, Kukwa M, Arun Kumar TK, Kunca V, Kušan I, Kuyper TW, Lado C, Læssøe T, Lainé P, Langer E, Larsson E, Larsson KH, Laursen G, Lechat C, Lee S, Lendemer JC, Levin L, Lindemann U, Lindström H, Liu X, Hernandez RCL, Llop E, Locsmándi C, Lodge DJ, Loizides M, Lőkös L, Luangsa-Ard J, Lüderitz M, Lumbsch T, Lutz M, Mahoney D, Malysheva E, Malysheva V, Manimohan P, Marin-Felix Y, Marques G, Martínez-Gil R, Marson G, Mata G, Matheny PB, Mathiassen GH, Matočec N, Mayrhofer H, Mehrabi M, Melo I, Mešić A, Methven AS, Miettinen O, Romero AMM, Miller AN, Mitchell JK, Moberg R, Moreau PA, Moreno G, Morozova O, Morte A, Muggia L, González GM, Myllys L, Nagy I, Nagy LG, Neves MA, Niemelä T, Nimis PL, Niveiro N, Noordeloos ME, Nordin A, Noumeur SR, Novozhilov Y, Nuytinck J, Ohenoja E, Fiuza PO, Orange A, Ordynets A, Ortiz-Santana B, Pacheco L, Pál-Fám F, Palacio M, Palice Z, Papp V, Pärtel K, Pawlowska J, Paz A, Peintner U, Pennycook S, Pereira OL, Daniëls PP, Pérez-De-Gregorio Capella MÀ, Del Amo CMP, Gorjón SP, Pérez-Ortega S, Pérez-Vargas I, Perry BA, Petersen JH, Petersen RH, Pfister DH, Phukhamsakda C, Piątek M, Piepenbring M, Pino-Bodas R, Esquivel JPP, Pirot P, Popov ES, Popoff O, Álvaro MP, Printzen C, Psurtseva N, Purahong W, Quijada L, Rambold G, Ramírez NA, Raja H, Raspé O, Raymundo T, Réblová M, Rebriev YA, de Dios Reyes García J, Ripoll MÁR, Richard F, Richardson MJ, Rico VJ, Robledo GL, Barbosa FR, Rodriguez-Caycedo C, Rodriguez-Flakus P, Ronikier A, Casas LR, Rusevska K, Saar G, Saar I, Salcedo I, Martínez SMS, Montoya CAS, Sánchez-Ramírez S, Sandoval-Sierra JV, Santamaria S, Monteiro JS, Schroers HJ, Schulz B, Schmidt-Stohn G, Schumacher T, Senn-Irlet B, Ševčíková H, Shchepin O, Shirouzu T, Shiryaev A, Siepe K, Sir EB, Sohrabi M, Soop K, Spirin V, Spribille T, Stadler M, Stalpers J, Stenroos S, Suija A, Sunhede S, Svantesson S, Svensson S, Svetasheva TY, Świerkosz K, Tamm H, Taskin H, Taudière A, Tedebrand JO, Lahoz RT, Temina M, Thell A, Thines M, Thor G, Thüs H, Tibell L, Tibell S, Timdal E, Tkalčec Z, Tønsberg T, Trichies G, Triebel D, Tsurykau A, Tulloss RE, Tuovinen V, Sosa MU, Urcelay C, Valade F, Garza RV, van den Boom P, Van Vooren N, Vasco-Palacios AM, Vauras J, Velasco Santos JM, Vellinga E, Verbeken A, Vetlesen P, Vizzini A, Voglmayr H, Volobuev S, von Brackel W, Voronina E, Walther G, Watling R, Weber E, Wedin M, Weholt Ø, Westberg M, Yurchenko E, Zehnálek P, Zhang H, Zhurbenko MP, Ekman S.

IMA Fungus. 2018 Jun;9(1):167-175. doi: 10.5598/imafungus.2018.09.01.10. Epub 2018 May 24.

42.

The multistress-induced Translocator protein (TSPO) differentially modulates storage lipids metabolism in seeds and seedlings.

Jurkiewicz P, Melser S, Maucourt M, Ayeb H, Veljanovski V, Maneta-Peyret L, Hooks M, Rolin D, Moreau P, Batoko H.

Plant J. 2018 Oct;96(2):274-286. doi: 10.1111/tpj.14028. Epub 2018 Aug 16.

PMID:
30003614
43.

Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials.

Chari A, Stewart AK, Russell SD, Moreau P, Herrmann J, Banchs J, Hajek R, Groarke J, Lyon AR, Batty GN, Ro S, Huang M, Iskander KS, Lenihan D.

Blood Adv. 2018 Jul 10;2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.

44.

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan G.

Leukemia. 2019 Jan;33(1):159-170. doi: 10.1038/s41375-018-0196-8. Epub 2018 Jul 2.

45.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM.

Lancet Haematol. 2018 Nov;5(11):e563-e598. doi: 10.1016/S2352-3026(18)30051-6. Epub 2018 Jun 18. Review.

46.

Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.

Peterlin P, Guillaume T, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Gallas P, Touzeau C, Gastinne T, Lok A, Thomare P, Chauvin C, Le Gouill S, Moreau P, Chevallier P.

Leuk Res Rep. 2018 Jan 17;9:16-17. doi: 10.1016/j.lrr.2018.01.002. eCollection 2018. No abstract available.

47.

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan GJ.

Blood. 2018 Aug 9;132(6):587-597. doi: 10.1182/blood-2018-03-840132. Epub 2018 Jun 8. Erratum in: Blood. 2018 Sep 27;132(13):1461.

48.

Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.

Moreau P, Mateos MV, Berenson JR, Weisel K, Lazzaro A, Song K, Dimopoulos MA, Huang M, Zahlten-Kumeli A, Stewart AK.

Lancet Oncol. 2018 Jul;19(7):953-964. doi: 10.1016/S1470-2045(18)30354-1. Epub 2018 Jun 1. Erratum in: Lancet Oncol. 2018 Aug;19(8):e382.

PMID:
29866475
49.

Clinical pharmacy in Kuwait: Services provided, perceptions and barriers.

Lemay J, Waheedi M, Al-Taweel D, Bayoud T, Moreau P.

Saudi Pharm J. 2018 May;26(4):481-486. doi: 10.1016/j.jsps.2018.02.011. Epub 2018 Feb 9.

50.

De novo biosynthesis of sterols and fatty acids in the Trypanosoma brucei procyclic form: Carbon source preferences and metabolic flux redistributions.

Millerioux Y, Mazet M, Bouyssou G, Allmann S, Kiema TR, Bertiaux E, Fouillen L, Thapa C, Biran M, Plazolles N, Dittrich-Domergue F, Crouzols A, Wierenga RK, Rotureau B, Moreau P, Bringaud F.

PLoS Pathog. 2018 May 29;14(5):e1007116. doi: 10.1371/journal.ppat.1007116. eCollection 2018 May.

Supplemental Content

Loading ...
Support Center